drugset / Trial / NCT01910441
Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
Compare the effect of Vildagliptin plus Metformin versus Glimepiride plus Metformin on glucose variability in T2DM patients.
Timeline
- Start
- 2013-07
- Primary completion
- 2014-09
- Completion
- 2014-09
Outcome
Outcome not reported
Stopped: “The study was terminated due to the unavailability of Continuous Glucose Monitoring sensors (CGMS) which were required to assess the primary end-point.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glimepiride | Small molecule | 1 mg | — |
| Comparator | Glimepiride | Small molecule | 6 mg | — |
| Subject | Vildagliptin | Other / unclassified | 50 mg | — |
| Background | Metformin | Small molecule | 1000 mg | — |
| Background | Metformin | Small molecule | 1500 mg | — |